These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28316135)

  • 41. Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.
    Kanouchi K; Narimatsu H; Ohnuma O; Morikane K; Fukao A
    Int J Hematol; 2017 Aug; 106(2):206-211. PubMed ID: 28390037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alternative assays to dRVVT and aPTT for lupus anticoagulant detection.
    Moore GW
    Am J Hematol; 2020 Aug; 95(8):992-998. PubMed ID: 32311119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison between a one-point dilute phospholipid APTT and the dilute Russell viper venom time for verification of lupus anticoagulants.
    Alving BM; Barr CF; Johansen LE; Tang DB
    Thromb Haemost; 1992 Jun; 67(6):672-8. PubMed ID: 1509408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants.
    Reda S; Brügelmann A; Müller J; Oldenburg J; Pötzsch B; Rühl H
    Sci Rep; 2020 Jul; 10(1):12221. PubMed ID: 32699227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Testing for Lupus Anticoagulants.
    Moore GW
    Semin Thromb Hemost; 2022 Sep; 48(6):643-660. PubMed ID: 35649428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for lupus anticoagulants in patients treated with vitamin K antagonists.
    Isert M; Miesbach W; Stoever G; Lindhoff-Last E; Linnemann B
    Int J Lab Hematol; 2015 Dec; 37(6):758-65. PubMed ID: 26224222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing.
    Genzen JR; Miller JL
    Am J Clin Pathol; 2005 Oct; 124(4):586-93. PubMed ID: 16146819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant.
    Forastiero RR; Falcón CR; Carreras LO
    Haemostasis; 1990; 20(4):208-14. PubMed ID: 2122955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
    Lambert M; Ferrard-Sasson G; Dubucquoi S; Hachulla E; Prin L; Hatron PY; Goudemand J; Boffa MC; Caron C
    Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of mixing test-specific cut-off in lupus anticoagulant mixing test interpretation for multiple reagents.
    Kumano O; Moore GW
    Thromb Res; 2023 Nov; 231():39-43. PubMed ID: 37801773
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
    Exner T; Triplett DA; Taberner DA; Howard MA; Harris EN
    Thromb Haemost; 1990 Nov; 64(3):478-84. PubMed ID: 2128977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.
    Moore GW; Peyrafitte M; Dunois C; Amiral J
    Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laboratory heterogeneity of the lupus anticoagulant: a multicentre study using different clotting assays on a panel of 78 samples. Hemostasis Committee of the "Société Française de Biologie Clinique".
    Thromb Res; 1992 May; 66(4):349-64. PubMed ID: 1412201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems.
    Hong SK; Hwang SM; Kim JE; Kim HK
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):739-44. PubMed ID: 22964767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA).
    Favaloro EJ
    Am J Hematol; 2019 Nov; 94(11):1290-1296. PubMed ID: 31379004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Commonalities and contrasts in recent guidelines for lupus anticoagulant detection.
    Moore GW
    Int J Lab Hematol; 2014 Jun; 36(3):364-73. PubMed ID: 24750683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A quantitative, semi-automated and computer-assisted test for lupus anticoagulant.
    Schjetlein R; Sletnes KE; Wisløff F
    Thromb Res; 1993 Jan; 69(2):239-50. PubMed ID: 8446953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
    Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mixing studies for lupus anticoagulant: mostly yes, sometimes no.
    Favaloro E
    Clin Chem Lab Med; 2020 Mar; 58(4):487-491. PubMed ID: 31874094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.